In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.

Altering the Medicare policy on injectable drugs is one way to reduce Medicare expenditures. Allowing self-administration will also free up hospital and clinic capacity for other patients.

To access the full article, download the PDF on the left-hand sidebar.

In the latest installment of the other words…

To access the full article, download the PDF on the left-hand sidebar.

Oft-mentioned in the lore of U.S. intelligence is…

Abstract

The transmission and storage of information in digital form coupled with the widespread proliferation of…

This article attempts to explain the so-called turn to the left of several Latin American political systems. There are several "lefts" involved based upon their ideological definitions and their different sociopolitical origins.